Invicta Diagnos, a company in the Healthcare Service Provider industry, reported revenue of ₹24 crore and net profit of ₹2.33 crore for the September 2026 quarter.
Invicta Diagnos. (NSE: INVICTA-SM) closed at ₹74.75 on 20 Nov 2026. Its market capitalisation is ₹94 crore and it trades at 21.1 times earnings.
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.